Title: start-bild
1How to handle peritoneal carcinomatosis
found at laparotomy
Lars Påhlman Dept. Surgery, Colorectal unit,
University Hospital, Uppsala, Sweden
2Swedish Gastrointestinal Tumour Adjuvant
Therapy Group
- Adjuvant Chemotherapy
- Intraperitoneal chemotherapy
- (5-FU 500 mg/m2/day i.p.)
- (Leucovorin 60 mg/m2/day i.v.)
- vs
- Surgery alone (Double - blinded)
3Swedish Gastrointestinal Tumour Adjuvant
Therapy Group
- Intraperitoneal chemotherapy
- 100 patients included
- (All Dukes stages)
-
- Postop. recovery not affected !
- Graf et. al. Int J Colorect Dis 1994 935-39
4Cytoreductive surgery i.p chemo
- Objectives
- Local effect on the surgical bed
- Early treatment start
- I.v. chemo does not reach the target
5Cytoreductive surgery i.p chemo
- Isolated peritoneal carcinomatosis
- Colorectal cancer
- Ovarian cancer
- Mesothelioma
- Peritoneal pseudomyxoma
- Other GI malignancies
6Cytoreductive surgery i.p chemo
- Uppsala series 1991 - 2010
- Type of malignancy
- Pseudomyxoma 197
- Colorectal cancer 259
- Mesothelioma 41
- Miscellaneous 46
- Total 543
7Cytoreductive surgery i.p chemo
- Uppsala series 1991 - 2010
- Many patients have had
- second - look operations
- Approx. two procedure per week
- in total ? 650 operations
8Cytoreductive surgery i.p chemo
- What survival figures do you expect ?
- A As good as for liver met !
- B Not as good as for liver met !
9Cytoreductive surgery i.p chemo
- If not as good as for liver metastasis,
how good is it ? - A 30 - 40 5-years survival
- B 20 - 30 5-years survival
- C 15 - 20 5-years survival
- D 10 - 15 5-years survival
10Cytoreductive surgery i.p chemo
Uppsala series Colon cancer
Mahteme et al Br J Cancer 2004
11Cytoreductive surgery i.p chemo
Uppsala series
Uppsala series Colon cancer
Mahteme et al Br J Cancer 2004
12Cytoreductive surgery i.p chemo
- Uppsala experience colon cancer
- Randomized trial
- Classic chemotherapy
- vs
- Cytoreductive surgery i.p chemo
13Cytoreductive surgery i.p chemo
- Randomized trial in Uppsala
- 50 patients included
- 46 evaluated
- Significant survival benefit in the
cytoreduction chemo group - 30 DSF 3-years survival
14Cytoreductive surgery i.p chemo
Cashin et al E J S O 2013
15Patient stage with a good CT
- Sigmoid cancer. You find 3 small nodules
on the surface of the liver easy to
remove - A Leave them and do a better staging
- B Take them out
- C Use intraoperative ultra sound.
16Patient stage with a good CT
- No good evidence but B is correct
- A Leave them and do a better staging
- B Take them out
- C Use intraoperative ultra sound.
17Patient stage with a good CT
- Right-sided cancer. Massive peritoneal
carcinosis around the primary - A Leave the primary for better staging
- B Resect the tumour and give adjuvant
chemotherapy - C Leave the primary and refer the
patient to a HIPEC-unit
18Patient stage with a good CT
- This is a classic case for C
- A Leave the primary for better staging
- B Resect the tumour and give adjuvant
chemotherapy - C Leave the primary and refer the
patient to a HIPEC-unit
19Patient stage with a good CT
- Right-sided cancer. Just a few deposits
around the primary tumour - A Leave the primary for better staging
- B Resect the tumour and give adjuvant
chemotherapy - C Leave the primary and refer the
patient to a HIPEC-unit
20Patient stage with a good CT
- Still C is correct
- A Leave the primary for better staging
- B Resect the tumour and give adjuvant
chemotherapy - C Leave the primary and refer the
patient to a HIPEC-unit
21Patient stage with a good CT
- Why always send all peritoneal carcinosis
to a HIPEC-unit - A Cytoreductive surgery is difficult if
retroperitoneum is opened - B An increase for distant spread
- C HIPEC does not work if retroperitoneum
is opened
22Patient stage with a good CT
- A correct ! It is very difficult to take
peritoneum out at the next operation - A Cytoreductive surgery is difficult if
retroperitoneum is opened - B An increase for distant spread
- C HIPEC does not work if retroperitoneum
is opened
23Cytoreductive surgery HIPEC
- Special issues
- Laparoscopy
- Drainage
- Distant metastases
- Morbidity
24Cytoreductive surgery HIPEC
- Take home message
- Always send the
- patients to a
- HIPEC-unit
25Cytoreductive surgery HIPEC
- Conclusion
- Pseudomyxoma Standard of care
- CRC Standard of care
- Ovarian cancer experimental ?
- Mesotelioma Standard of care ?
- Gastric cancer No